Tetsu Shinkai - Concepedia

Author

Tetsu Shinkai

Also Known As

M Tabata, S Tetsu, T Shinkai, T. Shinkai, TETSU SHINKAI, TETSU SHINKAI, M.D., Tetsu SHINKAI, Tetsu Shinkai, Tetsu Shinkai, M.D, Tetsu Shinkai, M.D.

215

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Shikoku Cancer Center National Cancer Center National Cancer Center Hospital East National Cancer Research Institute Tokyo National Hospital

About

Tetsu Shinkai is an author at Shikoku Cancer Center specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	58	2.1K
2	Health Sciences	18	30	1.1K
3	Cell Biology	3	3	142
4	Biostatistics	1	1	10
5	Classical Hematology	1	1	17

Tetsu Shinkai

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904) Shinzoh Kudoh, Koji Takeda, Kazuhiko Nakagawa, Journal of Clinical Oncology	2006	365
Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer Riichiroh Maruyama, Yutaka Nishiwaki, Tomohide Tamura, Journal of Clinical Oncology	2008	364
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer Seiji Niho, Hideo Kunitoh, Hiroshi Nokihara, Lung Cancer	2012	211
The Incidence of Secondary Tumors of the Heart and Pericardium: A 10-Year Study Tetsu Shinkai, Keigo Tominaga, Yukío Shimosato Japanese Journal of Clinical Oncology	1988	170
A Phase I Dose-Escalation Study of ZD6474 in Japanese Patients with Solid, Malignant Tumors Tomohide Tamura, Hironobu Minami, Yasuhide Yamada, Journal of Thoracic Oncology Dose-escalation StudyMedicineMalignant TumorsCancer TreatmentClinical Radiation Oncology	2006	130
Phase I Study and Pharmacokinetics of CPT-11 With 5-Day Continuous Infusion Y. Ohe, Yusuke Sasaki, Tetsu Shinkai, JNCI Journal of the National Cancer Institute OncologyMedicineCancer ManagementMetronomic TherapyCancer Cell Biology	1992	122
Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study Kaoru Kubota, Toyoaki Hida, Satoshi Ishikura, The Lancet Oncology Radiation TherapyMedicineRandomised Phase 3Thoracic RadiotherapyCancer Treatment	2013	115
Pharmacokinetics of (glycolato-0,0?)-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin Yasutsuna Sasaki, Tomohide Tamura, Kenji Eguchi, Cancer Chemotherapy and Pharmacology Medicinal ChemistryOncology-Diammine PlatinumMedicineNew Platinum Derivative	1989	97
A Randomized, Double-Blind, Phase IIa Dose-Finding Study of Vandetanib (ZD6474) in Japanese Patients With Non-Small Cell Lung Cancer Katsuyuki Kiura, Kazuhiko Nakagawa, Tetsu Shinkai, Journal of Thoracic Oncology OncologyMedicineMetronomic TherapyBronchial NeoplasmCancer Treatment	2008	93
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group Kenichi Inoue, Kazuhiko Nakagami, Mitsuhiro Mizutani, Breast Cancer Research and Treatment Breast OncologyMedicinePhase Iii TrialClinical TrialsBreast Cancer	2009	89

Page 1